Global Carmustine Market Growth 2025-2031
The global Carmustine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Carmustine players cover Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Carmustine Industry Forecast” looks at past sales and reviews total world Carmustine sales in 2024, providing a comprehensive analysis by region and market sector of projected Carmustine sales for 2025 through 2031. With Carmustine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carmustine industry.
This Insight Report provides a comprehensive analysis of the global Carmustine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Carmustine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carmustine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carmustine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carmustine.
This report presents a comprehensive overview, market shares, and growth opportunities of Carmustine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
What is the 10-year outlook for the global Carmustine market?
What factors are driving Carmustine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Carmustine market opportunities vary by end market size?
How does Carmustine break out by Type, by Application?
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
United States market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Carmustine is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Carmustine players cover Amneal Pharms, Arbor Pharms, Emcure Pharms, Navinta, STI Pharma, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “Carmustine Industry Forecast” looks at past sales and reviews total world Carmustine sales in 2024, providing a comprehensive analysis by region and market sector of projected Carmustine sales for 2025 through 2031. With Carmustine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Carmustine industry.
This Insight Report provides a comprehensive analysis of the global Carmustine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Carmustine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Carmustine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Carmustine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Carmustine.
This report presents a comprehensive overview, market shares, and growth opportunities of Carmustine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
- 100mg Injection
- 125mg Injection
- Glioma
- Glioblastoma Multiforme
- Medulloblastoma and Astrocytoma
- Multiple Myeloma
- Lymphoma
- Others
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Amneal Pharms
- Arbor Pharms
- Emcure Pharms
- Navinta
- STI Pharma
- Obvius Pharmaceuticals
- MGI Pharma
- Marcan Pharmaceuticals
- Eisai
- Bristol-Myers Squibb
- Pharmaplan
- Sanli Ilac
- Zydus Pharmaceuticals
- Tianjin Kingyork
What is the 10-year outlook for the global Carmustine market?
What factors are driving Carmustine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Carmustine market opportunities vary by end market size?
How does Carmustine break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Carmustine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Carmustine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Carmustine by Country/Region, 2020, 2024 & 2031
2.2 Carmustine Segment by Type
2.2.1 100mg Injection
2.2.2 125mg Injection
2.3 Carmustine Sales by Type
2.3.1 Global Carmustine Sales Market Share by Type (2020-2025)
2.3.2 Global Carmustine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Carmustine Sale Price by Type (2020-2025)
2.4 Carmustine Segment by Application
2.4.1 Glioma
2.4.2 Glioblastoma Multiforme
2.4.3 Medulloblastoma and Astrocytoma
2.4.4 Multiple Myeloma
2.4.5 Lymphoma
2.4.6 Others
2.5 Carmustine Sales by Application
2.5.1 Global Carmustine Sale Market Share by Application (2020-2025)
2.5.2 Global Carmustine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Carmustine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Carmustine Breakdown Data by Company
3.1.1 Global Carmustine Annual Sales by Company (2020-2025)
3.1.2 Global Carmustine Sales Market Share by Company (2020-2025)
3.2 Global Carmustine Annual Revenue by Company (2020-2025)
3.2.1 Global Carmustine Revenue by Company (2020-2025)
3.2.2 Global Carmustine Revenue Market Share by Company (2020-2025)
3.3 Global Carmustine Sale Price by Company
3.4 Key Manufacturers Carmustine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carmustine Product Location Distribution
3.4.2 Players Carmustine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CARMUSTINE BY GEOGRAPHIC REGION
4.1 World Historic Carmustine Market Size by Geographic Region (2020-2025)
4.1.1 Global Carmustine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Carmustine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Carmustine Market Size by Country/Region (2020-2025)
4.2.1 Global Carmustine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Carmustine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Carmustine Sales Growth
4.4 APAC Carmustine Sales Growth
4.5 Europe Carmustine Sales Growth
4.6 Middle East & Africa Carmustine Sales Growth
5 AMERICAS
5.1 Americas Carmustine Sales by Country
5.1.1 Americas Carmustine Sales by Country (2020-2025)
5.1.2 Americas Carmustine Revenue by Country (2020-2025)
5.2 Americas Carmustine Sales by Type (2020-2025)
5.3 Americas Carmustine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carmustine Sales by Region
6.1.1 APAC Carmustine Sales by Region (2020-2025)
6.1.2 APAC Carmustine Revenue by Region (2020-2025)
6.2 APAC Carmustine Sales by Type (2020-2025)
6.3 APAC Carmustine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Carmustine by Country
7.1.1 Europe Carmustine Sales by Country (2020-2025)
7.1.2 Europe Carmustine Revenue by Country (2020-2025)
7.2 Europe Carmustine Sales by Type (2020-2025)
7.3 Europe Carmustine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Carmustine by Country
8.1.1 Middle East & Africa Carmustine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Carmustine Revenue by Country (2020-2025)
8.2 Middle East & Africa Carmustine Sales by Type (2020-2025)
8.3 Middle East & Africa Carmustine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Carmustine
10.3 Manufacturing Process Analysis of Carmustine
10.4 Industry Chain Structure of Carmustine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Carmustine Distributors
11.3 Carmustine Customer
12 WORLD FORECAST REVIEW FOR CARMUSTINE BY GEOGRAPHIC REGION
12.1 Global Carmustine Market Size Forecast by Region
12.1.1 Global Carmustine Forecast by Region (2026-2031)
12.1.2 Global Carmustine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Carmustine Forecast by Type (2026-2031)
12.7 Global Carmustine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Amneal Pharms
13.1.1 Amneal Pharms Company Information
13.1.2 Amneal Pharms Carmustine Product Portfolios and Specifications
13.1.3 Amneal Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Amneal Pharms Main Business Overview
13.1.5 Amneal Pharms Latest Developments
13.2 Arbor Pharms
13.2.1 Arbor Pharms Company Information
13.2.2 Arbor Pharms Carmustine Product Portfolios and Specifications
13.2.3 Arbor Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Arbor Pharms Main Business Overview
13.2.5 Arbor Pharms Latest Developments
13.3 Emcure Pharms
13.3.1 Emcure Pharms Company Information
13.3.2 Emcure Pharms Carmustine Product Portfolios and Specifications
13.3.3 Emcure Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Emcure Pharms Main Business Overview
13.3.5 Emcure Pharms Latest Developments
13.4 Navinta
13.4.1 Navinta Company Information
13.4.2 Navinta Carmustine Product Portfolios and Specifications
13.4.3 Navinta Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Navinta Main Business Overview
13.4.5 Navinta Latest Developments
13.5 STI Pharma
13.5.1 STI Pharma Company Information
13.5.2 STI Pharma Carmustine Product Portfolios and Specifications
13.5.3 STI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 STI Pharma Main Business Overview
13.5.5 STI Pharma Latest Developments
13.6 Obvius Pharmaceuticals
13.6.1 Obvius Pharmaceuticals Company Information
13.6.2 Obvius Pharmaceuticals Carmustine Product Portfolios and Specifications
13.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Obvius Pharmaceuticals Main Business Overview
13.6.5 Obvius Pharmaceuticals Latest Developments
13.7 MGI Pharma
13.7.1 MGI Pharma Company Information
13.7.2 MGI Pharma Carmustine Product Portfolios and Specifications
13.7.3 MGI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MGI Pharma Main Business Overview
13.7.5 MGI Pharma Latest Developments
13.8 Marcan Pharmaceuticals
13.8.1 Marcan Pharmaceuticals Company Information
13.8.2 Marcan Pharmaceuticals Carmustine Product Portfolios and Specifications
13.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Marcan Pharmaceuticals Main Business Overview
13.8.5 Marcan Pharmaceuticals Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Carmustine Product Portfolios and Specifications
13.9.3 Eisai Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Carmustine Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 Pharmaplan
13.11.1 Pharmaplan Company Information
13.11.2 Pharmaplan Carmustine Product Portfolios and Specifications
13.11.3 Pharmaplan Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pharmaplan Main Business Overview
13.11.5 Pharmaplan Latest Developments
13.12 Sanli Ilac
13.12.1 Sanli Ilac Company Information
13.12.2 Sanli Ilac Carmustine Product Portfolios and Specifications
13.12.3 Sanli Ilac Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanli Ilac Main Business Overview
13.12.5 Sanli Ilac Latest Developments
13.13 Zydus Pharmaceuticals
13.13.1 Zydus Pharmaceuticals Company Information
13.13.2 Zydus Pharmaceuticals Carmustine Product Portfolios and Specifications
13.13.3 Zydus Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zydus Pharmaceuticals Main Business Overview
13.13.5 Zydus Pharmaceuticals Latest Developments
13.14 Tianjin Kingyork
13.14.1 Tianjin Kingyork Company Information
13.14.2 Tianjin Kingyork Carmustine Product Portfolios and Specifications
13.14.3 Tianjin Kingyork Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tianjin Kingyork Main Business Overview
13.14.5 Tianjin Kingyork Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Carmustine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Carmustine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Carmustine by Country/Region, 2020, 2024 & 2031
2.2 Carmustine Segment by Type
2.2.1 100mg Injection
2.2.2 125mg Injection
2.3 Carmustine Sales by Type
2.3.1 Global Carmustine Sales Market Share by Type (2020-2025)
2.3.2 Global Carmustine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Carmustine Sale Price by Type (2020-2025)
2.4 Carmustine Segment by Application
2.4.1 Glioma
2.4.2 Glioblastoma Multiforme
2.4.3 Medulloblastoma and Astrocytoma
2.4.4 Multiple Myeloma
2.4.5 Lymphoma
2.4.6 Others
2.5 Carmustine Sales by Application
2.5.1 Global Carmustine Sale Market Share by Application (2020-2025)
2.5.2 Global Carmustine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Carmustine Sale Price by Application (2020-2025)
3 GLOBAL BY COMPANY
3.1 Global Carmustine Breakdown Data by Company
3.1.1 Global Carmustine Annual Sales by Company (2020-2025)
3.1.2 Global Carmustine Sales Market Share by Company (2020-2025)
3.2 Global Carmustine Annual Revenue by Company (2020-2025)
3.2.1 Global Carmustine Revenue by Company (2020-2025)
3.2.2 Global Carmustine Revenue Market Share by Company (2020-2025)
3.3 Global Carmustine Sale Price by Company
3.4 Key Manufacturers Carmustine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Carmustine Product Location Distribution
3.4.2 Players Carmustine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR CARMUSTINE BY GEOGRAPHIC REGION
4.1 World Historic Carmustine Market Size by Geographic Region (2020-2025)
4.1.1 Global Carmustine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Carmustine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Carmustine Market Size by Country/Region (2020-2025)
4.2.1 Global Carmustine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Carmustine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Carmustine Sales Growth
4.4 APAC Carmustine Sales Growth
4.5 Europe Carmustine Sales Growth
4.6 Middle East & Africa Carmustine Sales Growth
5 AMERICAS
5.1 Americas Carmustine Sales by Country
5.1.1 Americas Carmustine Sales by Country (2020-2025)
5.1.2 Americas Carmustine Revenue by Country (2020-2025)
5.2 Americas Carmustine Sales by Type (2020-2025)
5.3 Americas Carmustine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Carmustine Sales by Region
6.1.1 APAC Carmustine Sales by Region (2020-2025)
6.1.2 APAC Carmustine Revenue by Region (2020-2025)
6.2 APAC Carmustine Sales by Type (2020-2025)
6.3 APAC Carmustine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Carmustine by Country
7.1.1 Europe Carmustine Sales by Country (2020-2025)
7.1.2 Europe Carmustine Revenue by Country (2020-2025)
7.2 Europe Carmustine Sales by Type (2020-2025)
7.3 Europe Carmustine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Carmustine by Country
8.1.1 Middle East & Africa Carmustine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Carmustine Revenue by Country (2020-2025)
8.2 Middle East & Africa Carmustine Sales by Type (2020-2025)
8.3 Middle East & Africa Carmustine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Carmustine
10.3 Manufacturing Process Analysis of Carmustine
10.4 Industry Chain Structure of Carmustine
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Carmustine Distributors
11.3 Carmustine Customer
12 WORLD FORECAST REVIEW FOR CARMUSTINE BY GEOGRAPHIC REGION
12.1 Global Carmustine Market Size Forecast by Region
12.1.1 Global Carmustine Forecast by Region (2026-2031)
12.1.2 Global Carmustine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Carmustine Forecast by Type (2026-2031)
12.7 Global Carmustine Forecast by Application (2026-2031)
13 KEY PLAYERS ANALYSIS
13.1 Amneal Pharms
13.1.1 Amneal Pharms Company Information
13.1.2 Amneal Pharms Carmustine Product Portfolios and Specifications
13.1.3 Amneal Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Amneal Pharms Main Business Overview
13.1.5 Amneal Pharms Latest Developments
13.2 Arbor Pharms
13.2.1 Arbor Pharms Company Information
13.2.2 Arbor Pharms Carmustine Product Portfolios and Specifications
13.2.3 Arbor Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Arbor Pharms Main Business Overview
13.2.5 Arbor Pharms Latest Developments
13.3 Emcure Pharms
13.3.1 Emcure Pharms Company Information
13.3.2 Emcure Pharms Carmustine Product Portfolios and Specifications
13.3.3 Emcure Pharms Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Emcure Pharms Main Business Overview
13.3.5 Emcure Pharms Latest Developments
13.4 Navinta
13.4.1 Navinta Company Information
13.4.2 Navinta Carmustine Product Portfolios and Specifications
13.4.3 Navinta Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Navinta Main Business Overview
13.4.5 Navinta Latest Developments
13.5 STI Pharma
13.5.1 STI Pharma Company Information
13.5.2 STI Pharma Carmustine Product Portfolios and Specifications
13.5.3 STI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 STI Pharma Main Business Overview
13.5.5 STI Pharma Latest Developments
13.6 Obvius Pharmaceuticals
13.6.1 Obvius Pharmaceuticals Company Information
13.6.2 Obvius Pharmaceuticals Carmustine Product Portfolios and Specifications
13.6.3 Obvius Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Obvius Pharmaceuticals Main Business Overview
13.6.5 Obvius Pharmaceuticals Latest Developments
13.7 MGI Pharma
13.7.1 MGI Pharma Company Information
13.7.2 MGI Pharma Carmustine Product Portfolios and Specifications
13.7.3 MGI Pharma Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 MGI Pharma Main Business Overview
13.7.5 MGI Pharma Latest Developments
13.8 Marcan Pharmaceuticals
13.8.1 Marcan Pharmaceuticals Company Information
13.8.2 Marcan Pharmaceuticals Carmustine Product Portfolios and Specifications
13.8.3 Marcan Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Marcan Pharmaceuticals Main Business Overview
13.8.5 Marcan Pharmaceuticals Latest Developments
13.9 Eisai
13.9.1 Eisai Company Information
13.9.2 Eisai Carmustine Product Portfolios and Specifications
13.9.3 Eisai Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Eisai Main Business Overview
13.9.5 Eisai Latest Developments
13.10 Bristol-Myers Squibb
13.10.1 Bristol-Myers Squibb Company Information
13.10.2 Bristol-Myers Squibb Carmustine Product Portfolios and Specifications
13.10.3 Bristol-Myers Squibb Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Bristol-Myers Squibb Main Business Overview
13.10.5 Bristol-Myers Squibb Latest Developments
13.11 Pharmaplan
13.11.1 Pharmaplan Company Information
13.11.2 Pharmaplan Carmustine Product Portfolios and Specifications
13.11.3 Pharmaplan Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Pharmaplan Main Business Overview
13.11.5 Pharmaplan Latest Developments
13.12 Sanli Ilac
13.12.1 Sanli Ilac Company Information
13.12.2 Sanli Ilac Carmustine Product Portfolios and Specifications
13.12.3 Sanli Ilac Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Sanli Ilac Main Business Overview
13.12.5 Sanli Ilac Latest Developments
13.13 Zydus Pharmaceuticals
13.13.1 Zydus Pharmaceuticals Company Information
13.13.2 Zydus Pharmaceuticals Carmustine Product Portfolios and Specifications
13.13.3 Zydus Pharmaceuticals Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 Zydus Pharmaceuticals Main Business Overview
13.13.5 Zydus Pharmaceuticals Latest Developments
13.14 Tianjin Kingyork
13.14.1 Tianjin Kingyork Company Information
13.14.2 Tianjin Kingyork Carmustine Product Portfolios and Specifications
13.14.3 Tianjin Kingyork Carmustine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Tianjin Kingyork Main Business Overview
13.14.5 Tianjin Kingyork Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Carmustine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Carmustine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 125mg Injection
Table 5. Global Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Carmustine Sales Market Share by Type (2020-2025)
Table 7. Global Carmustine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Carmustine Revenue Market Share by Type (2020-2025)
Table 9. Global Carmustine Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Carmustine Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Carmustine Sale Market Share by Application (2020-2025)
Table 12. Global Carmustine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Carmustine Revenue Market Share by Application (2020-2025)
Table 14. Global Carmustine Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Carmustine Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Carmustine Sales Market Share by Company (2020-2025)
Table 17. Global Carmustine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Carmustine Revenue Market Share by Company (2020-2025)
Table 19. Global Carmustine Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Carmustine Producing Area Distribution and Sales Area
Table 21. Players Carmustine Products Offered
Table 22. Carmustine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Carmustine Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Carmustine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Carmustine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Carmustine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Carmustine Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Carmustine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Carmustine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Carmustine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Carmustine Sales Market Share by Country (2020-2025)
Table 35. Americas Carmustine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Carmustine Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Carmustine Sales Market Share by Region (2020-2025)
Table 40. APAC Carmustine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Carmustine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Carmustine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Carmustine
Table 52. Key Market Challenges & Risks of Carmustine
Table 53. Key Industry Trends of Carmustine
Table 54. Carmustine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Carmustine Distributors List
Table 57. Carmustine Customer List
Table 58. Global Carmustine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Carmustine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Carmustine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Carmustine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Carmustine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Carmustine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Carmustine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Carmustine Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Carmustine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Carmustine Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Carmustine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Amneal Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 73. Amneal Pharms Carmustine Product Portfolios and Specifications
Table 74. Amneal Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Amneal Pharms Main Business
Table 76. Amneal Pharms Latest Developments
Table 77. Arbor Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 78. Arbor Pharms Carmustine Product Portfolios and Specifications
Table 79. Arbor Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Arbor Pharms Main Business
Table 81. Arbor Pharms Latest Developments
Table 82. Emcure Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 83. Emcure Pharms Carmustine Product Portfolios and Specifications
Table 84. Emcure Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. Emcure Pharms Main Business
Table 86. Emcure Pharms Latest Developments
Table 87. Navinta Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 88. Navinta Carmustine Product Portfolios and Specifications
Table 89. Navinta Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Navinta Main Business
Table 91. Navinta Latest Developments
Table 92. STI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 93. STI Pharma Carmustine Product Portfolios and Specifications
Table 94. STI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. STI Pharma Main Business
Table 96. STI Pharma Latest Developments
Table 97. Obvius Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 98. Obvius Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 99. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Obvius Pharmaceuticals Main Business
Table 101. Obvius Pharmaceuticals Latest Developments
Table 102. MGI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 103. MGI Pharma Carmustine Product Portfolios and Specifications
Table 104. MGI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. MGI Pharma Main Business
Table 106. MGI Pharma Latest Developments
Table 107. Marcan Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 108. Marcan Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 109. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Marcan Pharmaceuticals Main Business
Table 111. Marcan Pharmaceuticals Latest Developments
Table 112. Eisai Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 113. Eisai Carmustine Product Portfolios and Specifications
Table 114. Eisai Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. Eisai Main Business
Table 116. Eisai Latest Developments
Table 117. Bristol-Myers Squibb Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 118. Bristol-Myers Squibb Carmustine Product Portfolios and Specifications
Table 119. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Bristol-Myers Squibb Main Business
Table 121. Bristol-Myers Squibb Latest Developments
Table 122. Pharmaplan Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 123. Pharmaplan Carmustine Product Portfolios and Specifications
Table 124. Pharmaplan Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Pharmaplan Main Business
Table 126. Pharmaplan Latest Developments
Table 127. Sanli Ilac Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 128. Sanli Ilac Carmustine Product Portfolios and Specifications
Table 129. Sanli Ilac Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. Sanli Ilac Main Business
Table 131. Sanli Ilac Latest Developments
Table 132. Zydus Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 133. Zydus Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 134. Zydus Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135. Zydus Pharmaceuticals Main Business
Table 136. Zydus Pharmaceuticals Latest Developments
Table 137. Tianjin Kingyork Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 138. Tianjin Kingyork Carmustine Product Portfolios and Specifications
Table 139. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Tianjin Kingyork Main Business
Table 141. Tianjin Kingyork Latest Developments
Table 1. Carmustine Annual Sales CAGR by Geographic Region (2020, 2024 & 2031) & ($ millions)
Table 2. Carmustine Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of 100mg Injection
Table 4. Major Players of 125mg Injection
Table 5. Global Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 6. Global Carmustine Sales Market Share by Type (2020-2025)
Table 7. Global Carmustine Revenue by Type (2020-2025) & ($ million)
Table 8. Global Carmustine Revenue Market Share by Type (2020-2025)
Table 9. Global Carmustine Sale Price by Type (2020-2025) & (USD/Pcs)
Table 10. Global Carmustine Sale by Application (2020-2025) & (K Pcs)
Table 11. Global Carmustine Sale Market Share by Application (2020-2025)
Table 12. Global Carmustine Revenue by Application (2020-2025) & ($ million)
Table 13. Global Carmustine Revenue Market Share by Application (2020-2025)
Table 14. Global Carmustine Sale Price by Application (2020-2025) & (USD/Pcs)
Table 15. Global Carmustine Sales by Company (2020-2025) & (K Pcs)
Table 16. Global Carmustine Sales Market Share by Company (2020-2025)
Table 17. Global Carmustine Revenue by Company (2020-2025) & ($ millions)
Table 18. Global Carmustine Revenue Market Share by Company (2020-2025)
Table 19. Global Carmustine Sale Price by Company (2020-2025) & (USD/Pcs)
Table 20. Key Manufacturers Carmustine Producing Area Distribution and Sales Area
Table 21. Players Carmustine Products Offered
Table 22. Carmustine Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 23. New Products and Potential Entrants
Table 24. Market M&A Activity & Strategy
Table 25. Global Carmustine Sales by Geographic Region (2020-2025) & (K Pcs)
Table 26. Global Carmustine Sales Market Share Geographic Region (2020-2025)
Table 27. Global Carmustine Revenue by Geographic Region (2020-2025) & ($ millions)
Table 28. Global Carmustine Revenue Market Share by Geographic Region (2020-2025)
Table 29. Global Carmustine Sales by Country/Region (2020-2025) & (K Pcs)
Table 30. Global Carmustine Sales Market Share by Country/Region (2020-2025)
Table 31. Global Carmustine Revenue by Country/Region (2020-2025) & ($ millions)
Table 32. Global Carmustine Revenue Market Share by Country/Region (2020-2025)
Table 33. Americas Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 34. Americas Carmustine Sales Market Share by Country (2020-2025)
Table 35. Americas Carmustine Revenue by Country (2020-2025) & ($ millions)
Table 36. Americas Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 37. Americas Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 38. APAC Carmustine Sales by Region (2020-2025) & (K Pcs)
Table 39. APAC Carmustine Sales Market Share by Region (2020-2025)
Table 40. APAC Carmustine Revenue by Region (2020-2025) & ($ millions)
Table 41. APAC Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 42. APAC Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 43. Europe Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 44. Europe Carmustine Revenue by Country (2020-2025) & ($ millions)
Table 45. Europe Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 46. Europe Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 47. Middle East & Africa Carmustine Sales by Country (2020-2025) & (K Pcs)
Table 48. Middle East & Africa Carmustine Revenue Market Share by Country (2020-2025)
Table 49. Middle East & Africa Carmustine Sales by Type (2020-2025) & (K Pcs)
Table 50. Middle East & Africa Carmustine Sales by Application (2020-2025) & (K Pcs)
Table 51. Key Market Drivers & Growth Opportunities of Carmustine
Table 52. Key Market Challenges & Risks of Carmustine
Table 53. Key Industry Trends of Carmustine
Table 54. Carmustine Raw Material
Table 55. Key Suppliers of Raw Materials
Table 56. Carmustine Distributors List
Table 57. Carmustine Customer List
Table 58. Global Carmustine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 59. Global Carmustine Revenue Forecast by Region (2026-2031) & ($ millions)
Table 60. Americas Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 61. Americas Carmustine Annual Revenue Forecast by Country (2026-2031) & ($ millions)
Table 62. APAC Carmustine Sales Forecast by Region (2026-2031) & (K Pcs)
Table 63. APAC Carmustine Annual Revenue Forecast by Region (2026-2031) & ($ millions)
Table 64. Europe Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 65. Europe Carmustine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 66. Middle East & Africa Carmustine Sales Forecast by Country (2026-2031) & (K Pcs)
Table 67. Middle East & Africa Carmustine Revenue Forecast by Country (2026-2031) & ($ millions)
Table 68. Global Carmustine Sales Forecast by Type (2026-2031) & (K Pcs)
Table 69. Global Carmustine Revenue Forecast by Type (2026-2031) & ($ millions)
Table 70. Global Carmustine Sales Forecast by Application (2026-2031) & (K Pcs)
Table 71. Global Carmustine Revenue Forecast by Application (2026-2031) & ($ millions)
Table 72. Amneal Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 73. Amneal Pharms Carmustine Product Portfolios and Specifications
Table 74. Amneal Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 75. Amneal Pharms Main Business
Table 76. Amneal Pharms Latest Developments
Table 77. Arbor Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 78. Arbor Pharms Carmustine Product Portfolios and Specifications
Table 79. Arbor Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 80. Arbor Pharms Main Business
Table 81. Arbor Pharms Latest Developments
Table 82. Emcure Pharms Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 83. Emcure Pharms Carmustine Product Portfolios and Specifications
Table 84. Emcure Pharms Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 85. Emcure Pharms Main Business
Table 86. Emcure Pharms Latest Developments
Table 87. Navinta Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 88. Navinta Carmustine Product Portfolios and Specifications
Table 89. Navinta Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 90. Navinta Main Business
Table 91. Navinta Latest Developments
Table 92. STI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 93. STI Pharma Carmustine Product Portfolios and Specifications
Table 94. STI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 95. STI Pharma Main Business
Table 96. STI Pharma Latest Developments
Table 97. Obvius Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 98. Obvius Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 99. Obvius Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 100. Obvius Pharmaceuticals Main Business
Table 101. Obvius Pharmaceuticals Latest Developments
Table 102. MGI Pharma Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 103. MGI Pharma Carmustine Product Portfolios and Specifications
Table 104. MGI Pharma Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 105. MGI Pharma Main Business
Table 106. MGI Pharma Latest Developments
Table 107. Marcan Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 108. Marcan Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 109. Marcan Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 110. Marcan Pharmaceuticals Main Business
Table 111. Marcan Pharmaceuticals Latest Developments
Table 112. Eisai Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 113. Eisai Carmustine Product Portfolios and Specifications
Table 114. Eisai Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 115. Eisai Main Business
Table 116. Eisai Latest Developments
Table 117. Bristol-Myers Squibb Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 118. Bristol-Myers Squibb Carmustine Product Portfolios and Specifications
Table 119. Bristol-Myers Squibb Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 120. Bristol-Myers Squibb Main Business
Table 121. Bristol-Myers Squibb Latest Developments
Table 122. Pharmaplan Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 123. Pharmaplan Carmustine Product Portfolios and Specifications
Table 124. Pharmaplan Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 125. Pharmaplan Main Business
Table 126. Pharmaplan Latest Developments
Table 127. Sanli Ilac Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 128. Sanli Ilac Carmustine Product Portfolios and Specifications
Table 129. Sanli Ilac Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 130. Sanli Ilac Main Business
Table 131. Sanli Ilac Latest Developments
Table 132. Zydus Pharmaceuticals Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 133. Zydus Pharmaceuticals Carmustine Product Portfolios and Specifications
Table 134. Zydus Pharmaceuticals Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 135. Zydus Pharmaceuticals Main Business
Table 136. Zydus Pharmaceuticals Latest Developments
Table 137. Tianjin Kingyork Basic Information, Carmustine Manufacturing Base, Sales Area and Its Competitors
Table 138. Tianjin Kingyork Carmustine Product Portfolios and Specifications
Table 139. Tianjin Kingyork Carmustine Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2025)
Table 140. Tianjin Kingyork Main Business
Table 141. Tianjin Kingyork Latest Developments
LIST OF FIGURES
Figure 1. Picture of Carmustine
Figure 2. Carmustine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Carmustine Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Carmustine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Carmustine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Carmustine Sales Market Share by Country/Region (2024)
Figure 10. Carmustine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg Injection
Figure 12. Product Picture of 125mg Injection
Figure 13. Global Carmustine Sales Market Share by Type in 2025
Figure 14. Global Carmustine Revenue Market Share by Type (2020-2025)
Figure 15. Carmustine Consumed in Glioma
Figure 16. Global Carmustine Market: Glioma (2020-2025) & (K Pcs)
Figure 17. Carmustine Consumed in Glioblastoma Multiforme
Figure 18. Global Carmustine Market: Glioblastoma Multiforme (2020-2025) & (K Pcs)
Figure 19. Carmustine Consumed in Medulloblastoma and Astrocytoma
Figure 20. Global Carmustine Market: Medulloblastoma and Astrocytoma (2020-2025) & (K Pcs)
Figure 21. Carmustine Consumed in Multiple Myeloma
Figure 22. Global Carmustine Market: Multiple Myeloma (2020-2025) & (K Pcs)
Figure 23. Carmustine Consumed in Lymphoma
Figure 24. Global Carmustine Market: Lymphoma (2020-2025) & (K Pcs)
Figure 25. Carmustine Consumed in Others
Figure 26. Global Carmustine Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Carmustine Sale Market Share by Application (2024)
Figure 28. Global Carmustine Revenue Market Share by Application in 2025
Figure 29. Carmustine Sales by Company in 2025 (K Pcs)
Figure 30. Global Carmustine Sales Market Share by Company in 2025
Figure 31. Carmustine Revenue by Company in 2025 ($ millions)
Figure 32. Global Carmustine Revenue Market Share by Company in 2025
Figure 33. Global Carmustine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Carmustine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Carmustine Sales 2020-2025 (K Pcs)
Figure 36. Americas Carmustine Revenue 2020-2025 ($ millions)
Figure 37. APAC Carmustine Sales 2020-2025 (K Pcs)
Figure 38. APAC Carmustine Revenue 2020-2025 ($ millions)
Figure 39. Europe Carmustine Sales 2020-2025 (K Pcs)
Figure 40. Europe Carmustine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Carmustine Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Carmustine Revenue 2020-2025 ($ millions)
Figure 43. Americas Carmustine Sales Market Share by Country in 2025
Figure 44. Americas Carmustine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Carmustine Sales Market Share by Type (2020-2025)
Figure 46. Americas Carmustine Sales Market Share by Application (2020-2025)
Figure 47. United States Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Carmustine Sales Market Share by Region in 2025
Figure 52. APAC Carmustine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Carmustine Sales Market Share by Type (2020-2025)
Figure 54. APAC Carmustine Sales Market Share by Application (2020-2025)
Figure 55. China Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Carmustine Sales Market Share by Country in 2025
Figure 63. Europe Carmustine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Carmustine Sales Market Share by Type (2020-2025)
Figure 65. Europe Carmustine Sales Market Share by Application (2020-2025)
Figure 66. Germany Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Carmustine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Carmustine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Carmustine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Carmustine in 2025
Figure 80. Manufacturing Process Analysis of Carmustine
Figure 81. Industry Chain Structure of Carmustine
Figure 82. Channels of Distribution
Figure 83. Global Carmustine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Carmustine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Carmustine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Carmustine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Carmustine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Carmustine Revenue Market Share Forecast by Application (2026-2031)
Figure 1. Picture of Carmustine
Figure 2. Carmustine Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Carmustine Sales Growth Rate 2020-2031 (K Pcs)
Figure 7. Global Carmustine Revenue Growth Rate 2020-2031 ($ millions)
Figure 8. Carmustine Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 9. Carmustine Sales Market Share by Country/Region (2024)
Figure 10. Carmustine Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 11. Product Picture of 100mg Injection
Figure 12. Product Picture of 125mg Injection
Figure 13. Global Carmustine Sales Market Share by Type in 2025
Figure 14. Global Carmustine Revenue Market Share by Type (2020-2025)
Figure 15. Carmustine Consumed in Glioma
Figure 16. Global Carmustine Market: Glioma (2020-2025) & (K Pcs)
Figure 17. Carmustine Consumed in Glioblastoma Multiforme
Figure 18. Global Carmustine Market: Glioblastoma Multiforme (2020-2025) & (K Pcs)
Figure 19. Carmustine Consumed in Medulloblastoma and Astrocytoma
Figure 20. Global Carmustine Market: Medulloblastoma and Astrocytoma (2020-2025) & (K Pcs)
Figure 21. Carmustine Consumed in Multiple Myeloma
Figure 22. Global Carmustine Market: Multiple Myeloma (2020-2025) & (K Pcs)
Figure 23. Carmustine Consumed in Lymphoma
Figure 24. Global Carmustine Market: Lymphoma (2020-2025) & (K Pcs)
Figure 25. Carmustine Consumed in Others
Figure 26. Global Carmustine Market: Others (2020-2025) & (K Pcs)
Figure 27. Global Carmustine Sale Market Share by Application (2024)
Figure 28. Global Carmustine Revenue Market Share by Application in 2025
Figure 29. Carmustine Sales by Company in 2025 (K Pcs)
Figure 30. Global Carmustine Sales Market Share by Company in 2025
Figure 31. Carmustine Revenue by Company in 2025 ($ millions)
Figure 32. Global Carmustine Revenue Market Share by Company in 2025
Figure 33. Global Carmustine Sales Market Share by Geographic Region (2020-2025)
Figure 34. Global Carmustine Revenue Market Share by Geographic Region in 2025
Figure 35. Americas Carmustine Sales 2020-2025 (K Pcs)
Figure 36. Americas Carmustine Revenue 2020-2025 ($ millions)
Figure 37. APAC Carmustine Sales 2020-2025 (K Pcs)
Figure 38. APAC Carmustine Revenue 2020-2025 ($ millions)
Figure 39. Europe Carmustine Sales 2020-2025 (K Pcs)
Figure 40. Europe Carmustine Revenue 2020-2025 ($ millions)
Figure 41. Middle East & Africa Carmustine Sales 2020-2025 (K Pcs)
Figure 42. Middle East & Africa Carmustine Revenue 2020-2025 ($ millions)
Figure 43. Americas Carmustine Sales Market Share by Country in 2025
Figure 44. Americas Carmustine Revenue Market Share by Country (2020-2025)
Figure 45. Americas Carmustine Sales Market Share by Type (2020-2025)
Figure 46. Americas Carmustine Sales Market Share by Application (2020-2025)
Figure 47. United States Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 48. Canada Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 49. Mexico Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 50. Brazil Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 51. APAC Carmustine Sales Market Share by Region in 2025
Figure 52. APAC Carmustine Revenue Market Share by Region (2020-2025)
Figure 53. APAC Carmustine Sales Market Share by Type (2020-2025)
Figure 54. APAC Carmustine Sales Market Share by Application (2020-2025)
Figure 55. China Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 56. Japan Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 57. South Korea Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 58. Southeast Asia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 59. India Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 60. Australia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 61. China Taiwan Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 62. Europe Carmustine Sales Market Share by Country in 2025
Figure 63. Europe Carmustine Revenue Market Share by Country (2020-2025)
Figure 64. Europe Carmustine Sales Market Share by Type (2020-2025)
Figure 65. Europe Carmustine Sales Market Share by Application (2020-2025)
Figure 66. Germany Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 67. France Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 68. UK Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 69. Italy Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 70. Russia Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 71. Middle East & Africa Carmustine Sales Market Share by Country (2020-2025)
Figure 72. Middle East & Africa Carmustine Sales Market Share by Type (2020-2025)
Figure 73. Middle East & Africa Carmustine Sales Market Share by Application (2020-2025)
Figure 74. Egypt Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 75. South Africa Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 76. Israel Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 77. Turkey Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 78. GCC Countries Carmustine Revenue Growth 2020-2025 ($ millions)
Figure 79. Manufacturing Cost Structure Analysis of Carmustine in 2025
Figure 80. Manufacturing Process Analysis of Carmustine
Figure 81. Industry Chain Structure of Carmustine
Figure 82. Channels of Distribution
Figure 83. Global Carmustine Sales Market Forecast by Region (2026-2031)
Figure 84. Global Carmustine Revenue Market Share Forecast by Region (2026-2031)
Figure 85. Global Carmustine Sales Market Share Forecast by Type (2026-2031)
Figure 86. Global Carmustine Revenue Market Share Forecast by Type (2026-2031)
Figure 87. Global Carmustine Sales Market Share Forecast by Application (2026-2031)
Figure 88. Global Carmustine Revenue Market Share Forecast by Application (2026-2031)
